Xeris Biopharma Holdings, Inc. (XERS) stock
XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.99+0.19 (+1.13%)
Close on Nov 18, 2026Market cap $3.10BP/E –Yield –
Xeris Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Xeris Biopharma's market cap was $2.87B on Nov 11, 2026, against $1.19B a year earlier. Over the last 5 years it ranged from $138.39M to $2.87B, with a median of $367.60M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.87B | +120.7% |
| 2025 | Dec 31, 2025 | $1.30B | +157.2% |
| 2024 | Dec 31, 2024 | $505.12M | +55.7% |
| 2023 | Dec 29, 2023 | $324.46M | +79.4% |
| 2022 | Dec 30, 2022 | $180.83M | -7.2% |
| 2021 | Dec 31, 2021 | $194.84M | – |
See a number that looks wrong?